Drugs / BQ-A Peptide Extract
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02742857 | Jul 2016 → Aug 2020 | — | Bioquark Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BQ-A Peptide Extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02742857 ↗ |
| Modality | Peptide | “intra-thecal bioactive peptides” NCT02742857 ↗ |
| Route | Intrathecal | “intra-thecal bioactive peptides” NCT02742857 ↗ |